Mandatory stockpiling in the EU: Rethinking today’s approach to protect tomorrow’s Generic Medicine supply
Biosimilars Market Review 2025
Review of the SPC Manufacturing Waiver: a 2025 Industry Report
Generics Market Review 2025
Short summary: Ramboll Report on Micropollutants in Urban Wastewater
Ramboll Report on Micropollutants in Urban Wastewater
(Short version) Critical Medicines Act: delivering a secure supply of critical medicines and active pharmaceutical ingredients in Europe
Market Access Barriers: An overview of key barriers to generic and biosimilar market entry in select EU trading partners
Critical Medicines Act: delivering a secure supply of critical medicines and active pharmaceutical ingredients in Europe
A new transatlantic partnership for the secure supply of medicines
The European Union and the United States are each other’s main trading partners for medicinal and pharmaceutical products, which are the EU’s most significant exports to the US and the second most significant US exports to the EU.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok